Moreover, a recently described B cell population, characterized by a low membrane expression of CD21, appeared particularly associated with vascular events in SSc patients: indeed, the proportion of circulating CD21low B cells was associated with sPAP, DLCO and FVC/DLCO ratio in SSc patients (91). Here, CR2 is linked to systemic sclerosis.